MALAT1 and metabolic syndrome: However, a meta-analysis, drawing from both literature and the Gene Expression Omnibus (GEO) database, suggests that the lncRNA MALAT1 could serve as a novel biomarker, not only for various cancers [55] but also for MetS-related diseases.